Cargando…

COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?

Detalles Bibliográficos
Autores principales: Paez Vargas, Juan José, Vidal González, Anxela, Pérez-Calvo, César, Flandes, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339404/
https://www.ncbi.nlm.nih.gov/pubmed/34366058
http://dx.doi.org/10.1016/j.chest.2021.03.028
_version_ 1783733592922259456
author Paez Vargas, Juan José
Vidal González, Anxela
Pérez-Calvo, César
Flandes, Javier
author_facet Paez Vargas, Juan José
Vidal González, Anxela
Pérez-Calvo, César
Flandes, Javier
author_sort Paez Vargas, Juan José
collection PubMed
description
format Online
Article
Text
id pubmed-8339404
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83394042021-08-06 COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation? Paez Vargas, Juan José Vidal González, Anxela Pérez-Calvo, César Flandes, Javier Chest Correspondence American College of Chest Physicians. Published by Elsevier Inc. 2021-08 2021-08-05 /pmc/articles/PMC8339404/ /pubmed/34366058 http://dx.doi.org/10.1016/j.chest.2021.03.028 Text en © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Paez Vargas, Juan José
Vidal González, Anxela
Pérez-Calvo, César
Flandes, Javier
COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title_full COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title_fullStr COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title_full_unstemmed COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title_short COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
title_sort covid-19 in the critically ill: too risky for high-dose anticoagulation?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339404/
https://www.ncbi.nlm.nih.gov/pubmed/34366058
http://dx.doi.org/10.1016/j.chest.2021.03.028
work_keys_str_mv AT paezvargasjuanjose covid19inthecriticallyilltooriskyforhighdoseanticoagulation
AT vidalgonzalezanxela covid19inthecriticallyilltooriskyforhighdoseanticoagulation
AT perezcalvocesar covid19inthecriticallyilltooriskyforhighdoseanticoagulation
AT flandesjavier covid19inthecriticallyilltooriskyforhighdoseanticoagulation